Table 3.

Comparison of baseline echocardiographic measures between patients with ≥ 15% decrease of GLS versus < 15% decrease at followup.

N = 204< 15% Decrease GLS, n = 165≥ 15% Decrease GLS, n = 39p
LVEDd mm, mean ± SD47 ± 547 ± 70.719
LVEDV ml, mean ± SD81 ± 2480 ± 240.795
LVESV ml, mean ± SD31 ± 1232 ± 130.667
LVEF %, mean ± SD62 ± 760 ± 80.106
Left atrial diameter mm, mean ± SD36 ± 635 ± 50.093
E mm/s, mean ± SD77 ± 1777 ± 210.114
E/A ratio, mean ± SD1.16 ± 0.361.03 ± 0.320.008
Lateral E′ cm/sec, mean ± SD11.49 ± 2.6810.15 ± 2.490.005
Lateral E′ ≤ 10 cm/s, n (%)45 (27)20 (51)0.005
sPAP mmHg, mean ± SD25 ± 830 ± 80.004
Elevated sPAP, n (%)10 (6)6 (15)0.036
TAPSE mm, mean ± SD23 ± 422 ± 40.031
Pericardial effusion, n (%)7 (4)1 (3)0.627
  • GLS: global longitudinal strain; LV: left ventricular; LVEDd: LV end-diastolic diameter; LVEDV: LV end-diastolic volume; LVESV: LV end-systolic volume; LVEF: LV ejection fraction; E/A: peak early (E) and late (A) diastolic velocities; sPAP: systolic pulmonary arterial pressure; TAPSE: tricuspid annular plane systolic excursion.